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ABSTRACT 
The FTO gene harbors variation with the strongest effect on adiposity and obesity risk. Previous 
data support a role for FTO variation in influencing food intake. We conducted a combined 
analysis of 16,094 boys and girls aged 1-18 years from 14 studies to examine: 1) the association 
between the FTO rs9939609 variant (or a proxy) and total energy and macronutrient intake; and 
2) the interaction between the FTO variant and dietary intake on BMI. We found that the BMI-
increasing allele (minor allele) of FTO variant was associated with increased total energy intake 
(effect per allele=14.3[5.9, 22.7] kcal/day, P=6.5×10-4) but not with protein, carbohydrate or fat 
intake. We also found that protein intake modified the association between the FTO variant and 
BMI (interactive effect per allele=0.08[0.03, 0.12]SDs, P for interaction=7.2×10-4): the 
association between FTO genotype and BMI was much stronger in individuals with high protein 
intake (effect per allele=0.10[0.07, 0.13]SDs, P=8.2×10-10) than in those with low intake (effect 
per allele=0.04[0.01, 0.07]SDs, P=0.02). Our results suggest that the FTO variant that confers a 
predisposition to higher BMI is associated with higher total energy intake and that lower dietary 
protein intake attenuates the association between FTO genotype and adiposity in children and 
adolescents. 
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Introduction 
Common single nucleotide polymorphisms (SNPs) located in the first intron of the fat mass and 
obesity associated (FTO) gene are the first adiposity/body mass index (BMI)-associated variants 
identified through genome-wide association studies (GWASs) (1-3), and to date this remains the 
locus with the largest influence on BMI in adults, as well as in children and adolescents (4). The 
mechanism by which FTO variants influence adiposity is unclear. Previous animal studies have 
suggested a role of Fto in regulating energy homeostasis, but it is unknown whether it influences 
energy intake (5; 6) or energy expenditure (7; 8). In addition, it is not clear which gene’s 
function is affected by the functional variant(s) at this locus: FTO itself or another gene located 
downstream or upstream of FTO, such as IRX3 (9) and RPGRIP1L(10). 
        In many human studies, the BMI-increasing allele of FTO variants has been reported to be 
associated with increased food intake, total energy intake, fat or protein intake (11-20), 
suggesting that diet mediates the association with BMI. However, these associations have not 
been replicated in a number of other studies (21-35).  In addition, there is an increasing interest 
in examining whether lifestyle factors influence the associations between FTO variants and 
adiposity. While there is evidence that physical activity reduces the effect of FTO on BMI, at 
least in adults(36), the few studies that have investigated interaction with dietary factors in 
relation to BMI/obesity have generated conflicting results potential interactions(12; 20; 26; 32; 
34; 35; 37; 38). Our recent large-scale meta-analysis indicated that FTO variants were associated 
with protein intake in adults and under-reporting of dietary intake in obese participants might be 
a major issue in the analysis (39).	Studies in children are of particular interest in this regard, 
since this population is less biased by comorbidities and their treatment and exposure to 
environmental contributors is shorter.  
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         Relatively small sample size of individual studies, modest genetic effect size, and 
inevitable measurement errors might be major reasons for these inconsistent observations. Thus, 
studies with larger sample size are needed to clarify interrelations between FTO variants, dietary 
intake, and adiposity. Herein we report the result of a combined analysis of 16,094 children and 
adolescents from 14 studies to examine whether 1) the FTO rs9939609 variant  (or a proxy SNP) 
is associated with dietary intake of total energy and macronutrients (protein, carbohydrate and 
fat); and 2) dietary intake influence the association between the FTO variant and BMI. 
  
Materials and Methods 
Study participants 
The current analysis included cross-sectional data on 16,094 children and adolescents (15,352 
whites, 478 African Americans, and 267 Asians) aged 1-18 years from 14 studies 
(Supplemental Table 1). The study design, recruitment of participants, and data collection of 
individual studies have been described in detail previously (14; 23; 24; 40-50). In each study, 
informed consent was obtained from subjects’ parents or guardians, and subjects (if appropriate). 
Each study was reviewed and approved by the local Institutional Review Board.  
        Study-specific characteristics for each study are shown in Supplemental Table 2. The 
ranges of mean values across studies were age 1.1 to 16.4 years, BMI 16.2 to 24.7 kg/m2, total 
energy intake1017 to 2423 kcal/day, total protein intake 12.9 to 16.8% (percentage of total 
energy intake), total carbohydrate 43.4 to 59.0%, and total fat intake 28.1 to 40.0%. 
Assessment of BMI and dietary intake 
BMI was calculated as body weight (kg)/height(m)2. Body weight and height were measured in 
all studies except for one study which used self-reported data in a subsample (Supplemental 
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Table 3). For two studies with children aged younger than 2 years, length (height) was measured 
in a supine position to the nearest millimeter (43; 48). Dietary intake (total energy, protein, 
carbohydrate, and fat) was assessed using validated food frequency questionnaires (FFQs) (four 
studies), multiple-day dietary/food records (three studies), multiple-day 24-hour recalls (four 
studies), both dietary records and 24-hour recalls (one study), diet history consulting and 
information system (one study), or brief-type self-administered diet history questionnaire (one 
study) (Supplemental Table 3). Macronutrient intake was expressed as the percentage of total 
energy intake.  
Genotyping 
FTO SNP rs9939609 or a proxy (linkage disequilibrium [LD] r2=1 in the corresponding ethnic 
group) was genotyped using direct genotyping methods or Illumina genome-wide genotyping 
arrays, or imputed using MACH (http://www.sph.umich.edu/csg/abecasis/MACH/) with a high 
imputation quality (r2=1) (Supplemental Table 4). The studies provided summary statistics 
based on data that met their quality control criteria for genotyping call rate, concordance in 
duplicate samples, and Hardy-Weinberg Equilibrium P-value. 
Statistical analysis 
A standardized analytical plan, described below, was sent to study analysts from the 14 studies and 
analyses were performed locally. BMI was transformed to age-standardized z-score by sex in 
each study before analysis. A linear regression model under additive allelic effects was applied 
to examine associations of FTO variant with BMI, total energy intake, and intake of fat, protein 
and carbohydrate (expressed as the percentage of total energy), adjusted for pubertal status (if 
available), physical activity (if available) and eigenvectors (GWAS data only). We additionally 
adjusted for BMI when evaluating the association between FTO variant and dietary intake. In 
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addition, the difference in BMI between the low and high dietary intake groups (dichotomized at 
medians in each study) was also examined. Interactions between FTO genotype and dietary 
intake on BMI were tested by including the respective interaction terms in the models (e.g., 
interaction term = rs9939609 SNP × total energy intake [dichotomized at the medians in each 
study]). We examined the association between FTO variant and BMI stratified by low and high 
dietary intake groups (dichotomized at medians in each study). All the analyses were conducted 
in boys and girls separately, except for one study that combined the data from boys and girls with 
sex as a covariate. Analyses were also conducted in each race and in cases and controls 
separately if studies included multiple ancestries or had a case-control design. 
Detailed summary statistics from each study were subsequently collected, and we pooled beta 
coefficients and standard errors from individual studies using the Mantel and Haenszel fixed 
effects method as well as the DerSimonian and Laird random effects method implemented in 
Stata, version 12 (StataCorp LP, College Station, Texas, USA). Significant P-value was 0.005 
after Bonferroni’s adjustment for 10 independent tests: FTO-BMI association (1 test), diet-BMI 
associations (3 tests; we considered total energy, protein, carbohydrate and fat intake as 3 
independent variables), FTO-diet associations (3 tests), and FTO-diet interactions (3 tests). 
Between-study heterogeneity was tested by Cochran’s Q statistic and quantified by the I2 value. 
Low heterogeneity was defined as an I2 value of 0%–25%, moderate heterogeneity as an I2 of 
25%–75%, and high heterogeneity as an I2 of 75%–100%. P for heterogeneity was derived from 
a chi-squared test. We also performed stratified meta-analyses in subgroups according to 
ethnicity (whites, African Americans, or Asian), sex, age group (mean age<10 vs. ≥10 years), 
geographic region (North America, Europe, or Asia), study sample size (n<500 vs. ≥500), study 
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design (population-based vs. case-control), dietary intake assessment method (dietary records or 
24-hour recalls vs. FFQ or others), and adjustment for physical activity (yes vs. no).  
 
Results 
FTO variants and BMI 
We found a significant association between the minor allele (A-allele) of the FTO SNP 
rs9939609 (or its proxies) and higher BMI in all participants combined (effect per allele=0.07 
[95% CI 0.05, 0.09] SDs, P=4.7×10-10) (Table 1). The association was significant in 15,352 
whites (effect per allele=0.08 [0.05, 0.10] SDs; P=2.9×10-11), but not in 478 African Americans 
(effect per allele=-0.12 [-0.26, 0.02] SDs; P=0.08) or 267 Asians (effect per allele=0.11 [-0.12, 
0.09] SDs P=0.87), separately. 
FTO variants and dietary intake 
The minor allele of the FTO variant was significantly associated with higher total energy intake 
in all participants combined (effect per allele =14.6 [6.3, 23.1] kcal/day, P=6.5×10-4), with no 
heterogeneity among studies (I2=0%) (Table 1). This association was unchanged after further 
adjustment for BMI (effect per allele =14.7 [6.3, 23.1] kcal/day, P=6.5×10-4). The association 
between FTO variant and total energy intake was found in Whites (P=0.001) and Asians (P=0.01) 
but not in African Americans (P=0.80), although directions of associations were consistent 
across ethnicities (P for heterogeneity=0.07) (Figure 1). In stratified meta-analyses according to 
sex, age group, geographic region, study design, dietary intake assessment method, and 
adjustment for physical activity (Supplemental Figure 1), the directions of the associations 
between FTO variant and total energy intake were consistent across subgroups. Of note, the 
association was stronger in studies with a mean age ≥10 years old than in studies with a mean 
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age <10 years old (effect per allele =25.3 vs. 4.2 kcal/day; P for heterogeneity=0.014). Since 
most studies had a mean age >7.5 years and three studies had a mean age between 1.0 to 3.5 
years old, we further examined the association between FTO variant and total energy intake 
according to three categories of age: studies with a mean age between 1.0 to 3.5 years old (effect 
per allele =2.4 kcal/day); studies with a mean age between 7.5 and 10 years old (effect per allele 
=10.6 kcal/day); and studies with a mean age ≥10 years old (effect per allele =25.3 kcal/day).  
       We did not find evidence for associations between FTO variant and intake of protein 
(P=0.10), carbohydrate (P=0.96) or fat (P=0.40), and there was a low or moderate heterogeneity 
among studies (I2 =0, 24, and 34%, respectively) (Table 1, Supplemental Figure 2, 3 and 4). 
Further adjustment for BMI did not notably change the results. 
        We also performed meta-analyses for FTO variant and dietary intake using the random 
effects method, resulting in similar findings (Supplemental Table 5).  
Dietary intake and BMI 
Higher total energy and protein intake were significantly associated with higher BMI 
(Supplemental Table 6). Difference in BMI between the high and low energy intake groups was 
0.04 [0.01, 0.02] SDs (P=0.004), and difference in BMI between the high and low protein intake 
groups was 0.09 [0.07, 0.12] SDs (P=5.0×10-10). There was no significant difference in BMI 
between the high and low carbohydrate intake groups (difference in BMI = -0.02 [-0.05, 0.01] 
SDs; P = 0.12), and a nominally significant difference in BMI between the high and low fat 
intake groups (difference in BMI = -0.03 [-0.06, -0.001] SDs; P = 0.04).  
Interaction between FTO variants and dietary intake on BMI 
We observed a significant interaction between FTO variant and dietary protein intake on BMI in 
all participants combined (effect per allele for interaction=0.08 [0.03, 0.12] SDs, P for 
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interaction =7.2×10-4), showing that lower protein intake attenuated the association between the 
FTO variant and BMI, with no heterogeneity among studies (I2=0%) (Table 2). In stratified 
analysis by low and high protein intake groups (dichotomized at medians of protein intake in 
each study: ranging from 12.9 to 16.8% across studies). The association between FTO variant 
and BMI among participants in the low protein intake group (effect per allele = 0.04 [0.01, 0.07] 
SDs, P=0.02) was significantly weaker than that in the high protein intake group (effect per 
allele = 0.10 [0.07, 0.13] SDs, P=8.2×10-10) (Table 2). Although the interaction was found in 
whites (P for interaction=0.001) but not in African Americans (P=0.84) or Asians (P=0.11) 
separately, there was no significant heterogeneity among these ethnic groups (P for 
heterogeneity =0.53) (Figure 2). In stratified meta-analyses (Supplemental Figure 5), we found 
similar interaction patterns between FTO variant and protein intake on BMI across subgroups 
divided by sex, age group, geographic region, study design, dietary intake assessment method, 
and adjustment for physical activity (all P for heterogeneity >0.11). 
        We did not find substantive evidence for interactions between FTO variant and total energy 
intake (P for interaction=0.20), carbohydrate intake (P for interaction=0.98) or fat intake (P for 
interaction=0.89) on BMI (Table 2 and Supplemental Figure 6, 7 and 8). The heterogeneity 
among studies was low (I2 =0, 15, and 5%, respectively).  In analyses stratified by levels of 
dietary intake, associations between FTO variant and BMI were similar in high and low intake 
groups (Table 2). 
        In addition, since there was little or no heterogeneity in interactions between FTO variant 
and dietary intake on BMI across studies, the results were similar when we performed meta-
analyses using the random effects method (Supplemental Table 7).  
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Discussion 
We confirmed the association between an index SNP in the FTO gene, rs9939609, (or its proxy) 
and BMI in white children and adolescents and in all participants combined, but did not detect 
significant association in African American or Asian children and adolescents. This might be due 
to a relatively small sample size used by African American or Asian studies included in the 
current analysis and/or to different LD patterns across FTO intron 1 between different ethnic 
groups, particularly in populations of African ancestry (4; 51).  Other index SNPs within FTO 
locus might be needed in future studies of African American children and adolescents. 
        Although studies of FTO association with dietary intake in adults have been more numerous 
and often better powered with larger sample sizes than similar studies conducted in children and 
adolescents, the reported results have been inconsistent (16-20; 25-34). Our and other studies 
even observed an inverse association between FTO variant and total energy intake in adults, 
which might be partly due to under-reporting of total energy intake among individuals with a 
higher BMI (19; 20; 39).  In the current analysis, we demonstrated an association between the 
BMI-increasing allele of the FTO variant and higher total energy intake. However, we did not 
observe significant association between FTO variants and percentages of energy derived from 
protein, which has been observed in adults(39), or other macronutrients.  
        An apparently stronger, and more consistently reported, effect of FTO on total energy 
intake in children and adolescents could have several explanations. The influence of social 
desirability bias and the underreporting issues are smaller in children than in adults (52-54). It is 
possible that the effect of FTO variation on appetite may be stronger in children and adolescents 
than in adults. Consistent with this hypothesis and with the idea that FTO genetic effects might 
vary over the life course, previous studies have reported an increasing effect of FTO variants on 
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BMI from early childhood to adolescence, with a subsequently decreasing effect throughout 
adulthood (49; 55-60). Our result is also consistent with this, as we observed a stronger 
association between FTO variant and total energy intake in studies of older children than in 
studies of younger children. 
        Several lines of evidence from animal and in vitro studies are consistent with the observed 
association between FTO variant and total energy intake in humans. It has been reported that 
overexpression of Fto in mice led to increased food intake (5), and Fto expression in 
hypothalamus was regulated by feeding, fasting, and energy restriction (61-67). Further studies 
showed that glucose and amino acid deprivation decreases Fto expression, suggesting a role of 
FTO in cellular nutrient sensing (68; 69), possibly acting via hypothalamic mTOR pathways 
known to regulate food intake (70). A recent study suggested a link between FTO, ghrelin (a key 
mediator of ingestive behavior), and impaired brain food-cue responsivity (71) in both animals 
and humans. Interestingly, a recent study has challenged the established view of FTO as the 
major gene associated with BMI and risk of obesity (9), reporting that the region of FTO intron 1 
harboring the BMI-associated variants are strongly associated with IRX3 gene (500kbp 
downstream of FTO intron 1) expression in cerebellar brain samples. However, it has been 
pointed out that the cerebellum is not primarily involved in food intake or appetite regulation and 
FTO expression may function in a site-dependent manner (72). In addition, another study 
suggested that RPGRIP1L, located >100 bp 5’ in the opposite transcriptional orientation of FTO, 
may be partly or exclusively responsible for the obesity susceptibility signal at the FTO 
locus(10).  
        One novel finding of our study is the interaction between the FTO variant and dietary 
protein intake on BMI. The effect size of FTO variant on BMI in children with a low protein 
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intake was much smaller than in children with a high protein intake, suggesting that low protein 
intake may attenuate the influence of FTO variation on BMI. A study of 354 Spanish children 
and adolescents reported a significant interaction between the FTO-rs9939609 variant and 
dietary saturated fat intake on BMI (38) and several adult studies also found interactions between 
the FTO variant and total fat or saturated fat intake on BMI and obesity risk (20; 26; 34), while 
no significant interaction between the FTO variant and dietary intake was observed  in our meta-
analysis of adult data(39). In addition, we previously found that dietary protein intake might 
modify the effects of FTO variants on changes in body composition, fat distribution and appetite 
in a two-year weight-loss trial (73; 74). A recent mouse study showed that loss of Fto gene 
altered protein utilization and body composition (6); and consistently, other studies also suggest 
that FTO may influence body composition through cellular sensing of amino acids (68; 69). 
Given the increasing evidence supporting the role of FTO in protein metabolism and body 
composition, future investigations on this topic might help to clarify the mechanisms underlying 
the observed interaction between the FTO variant and protein intake on BMI. 
        Major strengths of our study include a large sample size of over 16,000 children and 
adolescents from 14 studies, a wide range of studies with data from early childhood to late 
adolescence, and the standardized analytical plan across studies.  There are some limitations in 
our study. Our analysis was conducted based on cross-sectional data. Measurement errors in 
dietary assessment are inevitable since self-reported data on dietary intake are all subject to bias. 
We only included dietary data on total energy and macronutrient intake but no data on specific 
foods, more specific types of fatty acids or micronutrients, which may potentially interact with 
the FTO variant as suggested previously (26; 34; 38). We were unable to examine other adiposity 
proxies, but were limited to the consideration of BMI, which cannot distinguish body 
15	
	
composition and does not give any indication about body fat distribution. To the best of our 
knowledge, this is the largest analysis of FTO variant and dietary intake in children and 
adolescents to date, though more data are needed to further confirm our results.  In particular, 
most of the children and adolescents included in our analysis are individuals of European 
ancestry (95% of all samples), and it is unknown whether our results can be generalized to other 
ethnic groups. 
        In summary, we demonstrated an association between the BMI-increasing allele of FTO 
variant and total energy intake based on data from 16,094 children and adolescents. Our data also 
show that dietary protein intake may modify the influence of FTO variants on BMI, offering new 
insight into the interrelationships between FTO genetic variants, dietary intake, and obesity. 
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Table 1 Associations between FTO SNP rs9939609, BMI, and dietary intake in a fixed effects meta-analysis of 
16,097 children and adolescents* 
 
 Model 1†  Model 2‡ 
 Beta (95% CI) P I2  Beta (95% CI) P I2 
BMI Z-score 0.07 (0.05, 0.09) 4.7×10-10 40%  - - - 
Total energy (kcal/day) 14.6 (6.3, 23.1) 6.5×10-4 0%  14.7 (6.3, 23.1) 6.5×10-4 6% 
Protein (% of energy) 0.0 (-0.1, 0.0) 0.10 0%  0.0 (-0.1, 0.0) 0.09 0% 
Carbohydrate (% of energy) 0.0 (-0.1, 0.1) 0.96 24%  0.0 (-0.1, 0.1) 0.92 15% 
Fat (% of energy) 0.1 (-0.1, 0.2) 0.40 34%  0.1 (-0.1, 0.2) 0.35 29% 
 
*Beta coefficients (95% CI) per minor allele of FTO rs9939609 or a proxy (r2=1) are given for each trait. Analyses 
from individual studies were conducted separately, and then combined by meta-analysis of 16,097 children and 
adolescents (15,352 Whites, 478 African Americans, and 267 Asians).  Values for proportion of variance explained 
by inter-study differences (I2) are also given. 
†Adjusted for age, pubertal status (if available), physical activity (if available), region (if available) and eigenvectors 
(GWAS data only).  
‡Further adjusted for BMI based on Model 1. 
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Table 2 Interaction between FTO SNP rs9939609 and dietary intake on BMI in a fixed effects meta-analysis of 
16,097 children and adolescents* 
 
*Data are beta coefficients (95% CI) per minor allele of FTO rs9939609 or a proxy (r2=1) for BMI (z-score), 
adjusted for age, pubertal status (if available), physical activity (if available), region (if available) and eigenvectors 
(GWAS data only). Analyses from individual studies were conducted separately, and then combined by meta-
analysis of 16,097 children and adolescents (15,352 Whites, 478 African Americans, and 267 Asians). Values for 
proportion of variance explained by inter-study differences (I2) are also given. 
†High and low intake groups were defined by medians of each dietary intake in each study. Medians of total energy 
intake ranged from 1160 to 2422 kcal/day, medians of protein intake ranged from 12.9 to 16.8%, medians of 
carbohydrate intake ranged from 44.2 to 59.0%, and medians of fat intake ranged from 28.0 to 41.0% across studies.  
 
 
 
  
 Association between FTO variant and BMI Interaction effect 
 Beta (95% CI) P I2 Beta (95% CI) P I2 
Total energy (kcal/day)       
Low intake group† 0.08 (0.05, 0.12) 2.9×10-7 25% 
-0.03 (-0.07, 0.02) 0.20 0% 
High intake group† 0.05 (0.02, 0.08) 8.0×10-4 25% 
Protein (% of total energy intake) 
Low intake group† 0.04 (0.01, 0.07) 0.02 0% 
0.08 (0.03, 0.12) 7.2×10-4 0% 
High intake group† 0.10 (0.07, 0.13) 8.2×10-10 34% 
Carbohydrate (% of total energy intake) 
Low intake group† 0.08 (0.05, 0.11) 1.6×10-6 20% 
0.00 (-0.04, 0.04) 0.98 10% 
High intake group† 0.07 (0.04, 0.10) 9.9×10-6 26% 
Fat (% of total energy intake) 
Low intake group† 0.08 (0.05, 0.11) 6.7×10-7 24% 
0.00 (-0.05, 0.05) 0.89 0% 
High intake group† 0.07 (0.03, 0.10) 4.1×10-5 34% 
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Figure Legend 
 
Figure 1 Forest plot of the association between FTO SNP rs9939609 and total energy intake in a 
fixed effects meta-analysis of 16,097 children and adolescents 
The studies are shown in boys (_B), girls (_G) or mixed, cases (_Case) and controls (_Control) 
for case-control studies, and whites (_W) and African Americans (_AA) for studies with multiple 
ethnicities separately, sorted by sample size (smallest to largest). The beta represents the 
difference in total energy intake per minor allele of SNP rs9939609 or a proxy (r2=1), adjusted 
for age, pubertal status (if available), physical activity (if available), region (if available) and 
eigenvectors (GWAS data only). 
 
Figure 2 Forest plot of the interaction between FTO SNP rs9939609 and dietary protein intake 
on BMI in a fixed effects meta-analysis of 16,097 children and adolescents 
The studies are shown in boys (_B), girls (_G) or mixed, cases (_Case) and controls (_Control) 
for case-control studies, and whites (_W) and African Americans (_AA) for studies with multiple 
ethnicities separately, sorted by sample size (smallest to largest). The beta represents the 
difference in BMI per minor allele of SNP rs9939609 or a proxy (r2=1) comparing participants in 
the high protein intake group to those in the low protein intake group, adjusted for age, pubertal 
status (if available), physical activity (if available), region (if available) and eigenvectors 
(GWAS data only). 
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Supplemental Figure 1 Association between FTO rs9939609 SNP or a proxy and total energy intake in a fixed 
effects meta-analysis of 16,097 children and adolescents stratified by study characteristics.  
 
Meta-analyses were stratified by geographic region, gender (one study with mixed data were not included), age 
group, sample size, study design, measurement of dietary intake, or adjustment for physical activity. The beta 
represents the difference in total energy intake (kcal/day) per minor allele of SNP rs9939609 or a proxy (r2=1), 
adjusted for age, physical activity (if available), region (if available) and eigenvectors (GWAS data only). 
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Supplemental Figure 2 Forest plot of the association between FTO rs9939609 SNP or a proxy and protein 
intake in a fixed effects meta-analysis of 16,097 children and adolescents 
 
The studies are shown in boys (_B), girls (_Y) or mixed (GENR study only), cases (_Case) and controls 
(_Control) for case-control studies, and whites (_W) and African Americans (_AA) for studies with multiple 
ethnicities separately, sorted by sample size (smallest to largest). The beta represents the difference in protein 
intake (% of energy) per minor allele of SNP rs9939609 or a proxy (r2=1), adjusted for age, physical activity (if 
available), region (if available) and eigenvectors (GWAS data only).  
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Supplemental Figure 3 Forest plot of the association between FTO rs9939609 SNP or a proxy and 
carbohydrate intake in a fixed effects meta-analysis of 16,097 children and adolescents 
 
The studies are shown in boys (_B), girls (_Y) or mixed (GENR study only), cases (_Case) and controls 
(_Control) for case-control studies, and whites (_W) and African Americans (_AA) for studies with multiple 
ethnicities separately, sorted by sample size (smallest to largest). The beta represents the difference in 
carbohydrate intake (% of energy) per minor allele of SNP rs9939609 or a proxy (r2=1), adjusted for age, 
physical activity (if available), region (if available) and eigenvectors (GWAS data only). 
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Supplemental Figure 4 Forest plot of the association between FTO rs9939609 SNP or a proxy and fat intake in 
a fixed effects meta-analysis of 16,097 children and adolescents 
 
The studies are shown in boys (_B), girls (_Y) or mixed (GENR study only), cases (_Case) and controls 
(_Control) for case-control studies, and whites (_W) and African Americans (_AA) for studies with multiple 
ethnicities separately, sorted by sample size (smallest to largest). The beta represents the difference in fat intake 
(% of energy) per minor allele of SNP rs9939609 or a proxy (r2=1), adjusted for age, physical activity (if 
available), region (if available) and eigenvectors (GWAS data only). 
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Supplemental Figure 5 Interaction between FTO rs9939609 SNP or a proxy and protein intake on BMI in a 
fixed effects meta-analysis of 16,097 children and adolescents stratified by study characteristics.  
 
Meta-analyses were stratified by geographic region, gender (one study with mixed data were not included), age 
group, sample size, study design, measurement of dietary intake, or adjustment for physical activity. The beta 
represents the difference in BMI per minor allele of SNP rs9939609 or a proxy (r2=1) comparing participants in 
the high protein intake group to those in the low protein intake group, adjusted for age, physical activity (if 
available), region (if available) and eigenvectors (GWAS data only). 
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Supplemental Figure 6 Forest plot of the interaction between FTO rs9939609 SNP or a proxy and total energy 
intake on BMI in a fixed effects meta-analysis of 16,097 children and adolescents 
 
The studies are shown in boys (_B), girls (_Y) or mixed (GENR study only), cases (_Case) and controls 
(_Control) for case-control studies, and whites (_W) and African Americans (_AA) for studies with multiple 
ethnicities separately, sorted by sample size (smallest to largest). The beta represents the difference in BMI per 
minor allele of SNP rs9939609 or a proxy (r2=1) comparing participants in the high energy intake group to 
those in the low energy intake group, adjusted for age, physical activity (if available), region (if available) and 
eigenvectors (GWAS data only). 
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Supplemental Figure 7 Forest plot of the interaction between FTO rs9939609 SNP or a proxy and 
carbohydrate intake on BMI in a fixed effects meta-analysis of 16,097 children and adolescents 
 
The studies are shown in boys (_B), girls (_Y) or mixed (GENR study only), cases (_Case) and controls 
(_Control) for case-control studies, and whites (_W) and African Americans (_AA) for studies with multiple 
ethnicities separately, sorted by sample size (smallest to largest). The beta represents the difference in BMI per 
minor allele of SNP rs9939609 or a proxy (r2=1) comparing participants in the high carbohydrate intake group 
to those in the low carbohydrate intake group, adjusted for age, physical activity (if available), region (if 
available) and eigenvectors (GWAS data only). 
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Supplemental Figure 8 Forest plot of the interaction between FTO rs9939609 SNP or a proxy and fat intake on 
BMI in a fixed effects meta-analysis of 16,097 children and adolescents 
 
The studies are shown in boys (_B), girls (_Y) or mixed (GENR study only), cases (_Case) and controls 
(_Control) for case-control studies, and whites (_W) and African Americans (_AA) for studies with multiple 
ethnicities separately, sorted by sample size (smallest to largest). The beta represents the difference in BMI per 
minor allele of SNP rs9939609 or a proxy (r2=1) comparing participants in the high fat intake group to those in 
the low fat intake group, adjusted for age, physical activity (if available), region (if available) and eigenvectors 
(GWAS data only). 
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Subtotal  (I-squared = 0.0%, p = 0.990)
GENESIS_G
PANIC_B
BAMSE_Control_G
BAMSE_Case_G
GENDAI_B
TEENAGE_G
STRIP_Control_B
GINI/LISA_B
LACHY_White_B
STRIP_Control_G
PANIC_G
Study
14.6 (6.2, 23.1)
14.0 (5.5, 22.5)
-18.0 (-139.7, 103.8)
29.6 (-94.2, 153.3)
130.0 (-90.7, 350.8)
10.4 (-63.6, 84.4)
34.0 (12.4, 55.5)
168.5 (-146.2, 483.1)
190.0 (-83.3, 463.3)
-1.5 (-25.7, 22.7)
133.2 (-18.9, 285.2)
9.7 (-66.1, 85.6)
-20.9 (-138.5, 96.7)
-66.8 (-166.0, 32.4)
-56.6 (-229.5, 116.3)
-2.0 (-115.4, 111.4)
23.3 (-58.4, 105.0)
40.7 (-7.7, 89.0)
-9.5 (-85.6, 66.6)
-6.5 (-58.0, 45.0)
17.8 (-27.0, 62.6)
-41.3 (-151.1, 68.5)
26.2 (-114.4, 166.8)
157.4 (-54.4, 369.1)
-1.0 (-27.7, 25.6)
25.5 (7.1, 44.0)
-26.8 (-228.3, 174.7)
157.2 (34.4, 280.0)
-4.7 (-28.6, 19.2)
38.6 (-23.5, 100.8)
-20.1 (-122.8, 82.6)
-65.9 (-196.0, 64.1)
127.6 (30.5, 224.7)
39.2 (-29.8, 108.1)
14.7 (-67.1, 96.4)
3.5 (-57.5, 64.5)
30.5 (-107.7, 168.7)
9.8 (-72.3, 91.9)
23.5 (-33.6, 80.6)
Beta (95% CI)
  0-500 -250 250 500
Heterogeneity between groups: p = 0.525
Overall  (I-squared = 0.0%, p = 0.688)
GENR
GENDAI_B
LEIPZIG_G
STRIP_Control_G
Shunan_Control_B
SWS_G
STRIP_Int_B
GINI/LISA_B
Subtotal  (I-squared = 0.0%, p = 0.980)
Study
GENESIS_B
Shunan_Control_G
BAMSE_Case_B
LACHY_White_B
STRIP_Int_G
ALSPAC_G
Shunan_Case_B
BAMSE_Control_G
BAMSE_Control_B
APEX_AA_B
GINI/LISA_G
APEX_AA_G
SWS_B
Afrian American (n=478)
BAMSE_Case_G
Subtotal  (I-squared = 23.4%, p = 0.271)
GENDAI_G
GENESIS_G
LACHY_AA_B
PANIC_B
PANIC_G
Subtotal  (I-squared = 0.0%, p = 0.569)
Asian (n=267)
TEENAGE_G
Shunan_Case_G
TEENAGE_B
STRIP_Control_B
LACHY_White_G
LEIPZIG_B
ALSPAC_B
White (n=15,352)
LACHY_AA_G
0.08 (0.03, 0.12)
0.01 (-0.14, 0.16)
-0.10 (-0.40, 0.21)
-0.01 (-0.51, 0.48)
0.39 (-0.23, 1.01)
0.22 (-0.13, 0.56)
0.03 (-0.22, 0.29)
-0.03 (-0.49, 0.42)
0.16 (-0.02, 0.34)
0.17 (-0.04, 0.37)
Beta (95% CI)
-0.01 (-0.19, 0.18)
0.09 (-0.40, 0.57)
0.14 (-0.33, 0.60)
1.07 (0.19, 1.94)
0.16 (-0.30, 0.63)
0.12 (0.02, 0.23)
0.15 (-0.19, 0.49)
0.12 (-0.33, 0.57)
0.31 (-0.25, 0.87)
0.13 (-0.45, 0.70)
0.14 (-0.05, 0.33)
0.38 (-0.27, 1.02)
0.11 (-0.12, 0.34)
0.78 (0.07, 1.49)
-0.03 (-0.31, 0.25)
-0.09 (-0.35, 0.18)
-0.06 (-0.25, 0.14)
-0.01 (-0.60, 0.59)
-0.07 (-0.46, 0.31)
0.12 (-0.27, 0.51)
0.07 (0.03, 0.12)
0.03 (-0.23, 0.29)
0.17 (-0.41, 0.75)
-0.13 (-0.44, 0.18)
-0.07 (-0.57, 0.44)
0.18 (-0.28, 0.63)
0.47 (-0.09, 1.03)
0.10 (-0.01, 0.21)
-0.38 (-0.87, 0.10)
  0-2 -1 1 2
